Exploring the reasons why melatonin can improve tinnitus

Medical Hypotheses

Volumn 75, Issue 2, 2010, Pages 190-191

  Pirodda, Antonio ^a   Raimondi, Maria Chiara ^a   Ferri, Gian Gaetano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; ENDOLYMPH; HEMODYNAMICS; HUMAN; INNER EAR; MUSCLE CONTRACTION; MUSCLE TONE; SKELETAL MUSCLE; SLEEP; SYMPATHETIC TONE; TENSOR TYMPANI MUSCLE; TINNITUS; VASODILATATION; DRUG EFFECTS; PATHOPHYSIOLOGY;

ANTIOXIDANTS; HUMANS; MELATONIN; MUSCLE TONUS; MUSCLE, SKELETAL; SLEEP; TENSOR TYMPANI; TINNITUS;

EID: 77954314558     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.02.018     Document Type: Article

References (19)

1. Lerner A.B., Case J.D., Takahashi Y., Lee T.H., Mori N. Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc 1958, 80:2587.
2. Paulis L., Šimko F. Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiol Res 2007, 56:671-684.
3. Tricoire H., Moller M., Chemineau P., Malpaux B. Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reproduction 2003, (Suppl. 61):311-321.
4. Cardinali D.P., Pevet P. Basic aspects of melatonin action. Sleep Med Rev 1998, 2:175-190.
5. Pandi-Perumal S.R., Trakht I., Srinivasan V., et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008, 85:335-353.
6. Megwalu U.C., Finnell J.E., Piccirillo J.F. The effects of melatonin on tinnitus and sleep. Otolaryngol Head Neck Surg 2006, 134:210-213.
7. Piccirillo JF. Melatonin. In: Langguth B, Hajak G, Kleinjung T, Cacace A, Moller ArR, editors. Progress in Brain Research 2007;166:331-3.
8. Neri G., De Stefano A., Baffa C., et al. Treatment of central and sensorineural tinnitus with orally administered melatonin and sulodexide: personal experience from a randomized controlled study. Acta Otorhinolaryngol Ital 2009, 29:86-91.
9. Kim J.B., Jung J.Y., Ahn J.C., Rhee C.K., Hwang H.J. Antioxidant and anti-apoptotic effect of melatonin on the vestibular hair cells of rat utricles. Clin Exp Octorhinolaryngol 2009, 2:6-12.
10. Bas E., Martinez-Soriano F., Làinez J.M., Marco J. An experimental comparative study dexamethasone, melatonin and tacrolimus in noise-induced hearing loss. Acta Otolaryngol 2009, 129:385-389.
11. Pirodda A., Saggese D., Ferri G.G., Giausa G., Grippo M.C., Gaddi A. The role of hypotension in the pathogenesis of sudden hearing loss. Audiology 1997, 36:98-108.
12. Pirodda A., Ferri G.G., Modugno G.C., Borghi C. Systemic hypotension and the development of acute sensorineural hearing loss in young healthy subjects. Arch Otolaryngol Head Neck Surg 2001, 127:1049-1052.
13. Pirodda A., Ferri G.G., Montana T., Riggio R., Innocenti G., Di Nino G. Hypotension as an isolated factor may not be sufficient to provoke hearing impairment. J Laryngol Otol 2004, 118:941-945.
14. Cagnacci A., Arangino S., Angiolucci M., et al. Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy. Clin Endocrinol (Oxf) 2001, 54:261-266.
15. Pirodda A., Brandolini C., Ferri G.G., Modugno G.C., Degli Esposti D., Borghi C. Inner ear dysfunction of uncertain origin: a multidisciplinary approach could give something more. Med Hypotheses 2009, 72:188-189.
16. Pirodda A., Brandolini C., Raimondi M.C., Modugno G.C. The possible role of proton pump inhibitors of the homeostasis of the inner ear. Med Hypotheses 2009, 72:325-326.
17. Tanaka H., Araki A., Ito J., Tasaki T., Miyamoto A., Cho K. Improvement of hypertonus after treatment for sleep disturbances in three patients with severe brain damage. Brain Dev 1997, 19:240-244.
18. Kurcer Z., Iraz M., Kelesyilmaz N., Kilic N., Olmez E. Beneficial effects of melatonin on diaphragmatic contractility and fatigability in Escherichia coli endotoxemic rats. Arzneimittelforschung 2006, 56:90-95.
19. Willis G.L., Turner E.J. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol Int 2007, 24:521-537.